These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25103934)

  • 1. Clinical value of plasma renin estimation in the management of hypertension.
    Brown MJ
    Am J Hypertens; 2014 Aug; 27(8):1013-6. PubMed ID: 25103934
    [No Abstract]   [Full Text] [Related]  

  • 2. John H. Laragh, MD: clinician-scientist.
    Sealey JE
    Am J Hypertens; 2014 Aug; 27(8):1019-23. PubMed ID: 25103936
    [No Abstract]   [Full Text] [Related]  

  • 3. Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
    Minami J; Ohno E; Furukata S; Ishimitsu T; Matsuoka H
    J Hum Hypertens; 2009 Oct; 23(10):683-6. PubMed ID: 19369955
    [No Abstract]   [Full Text] [Related]  

  • 4. Antihypertensive treatment and plasma renin activity in essential hypertension.
    Chen WY; Hsieh BS; Yen TS; Cheng JT; Yang SM
    Taiwan Yi Xue Hui Za Zhi; 1976 Dec; 75(12):665-73. PubMed ID: 1071754
    [No Abstract]   [Full Text] [Related]  

  • 5. Renin profiling to predict response to antihypertensive therapy.
    Blaufox MD; Wassertheil-Smoller S
    JAMA; 1999 Mar; 281(9):793-4. PubMed ID: 10070992
    [No Abstract]   [Full Text] [Related]  

  • 6. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension.
    Laragh J
    Am J Hypertens; 2001 Jun; 14(6 Pt 1):491-503. PubMed ID: 11411727
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between plasma renin activity and blood pressure response to antihypertensive agents. A proposal for management of essential and renal hypertension.
    Tanaka K; Fukiyama K; Kumamoto K; Yamamoto Y; Oniki H; Omae T
    Jpn Circ J; 1975 Jul; 39(7):805-10. PubMed ID: 1159940
    [No Abstract]   [Full Text] [Related]  

  • 8. Unsuccessfully Treated Hypertension: A Major Public Health Problem With a Potential Solution.
    Furberg CD; Sealey JE; Blumenfeld JD
    Am J Hypertens; 2017 Sep; 30(9):857-860. PubMed ID: 28482060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?
    Minami J; Ishimitsu T; Matsuoka H
    Am J Hypertens; 2008 Feb; 21(2):130-1; author reply 132. PubMed ID: 18268482
    [No Abstract]   [Full Text] [Related]  

  • 10. Aliskiren fails to lower blood pressure in patients who have either low PRA levels or whose PRA falls insufficiently or reactively rises.
    Sealey JE; Laragh JH
    Am J Hypertens; 2009 Jan; 22(1):112-21. PubMed ID: 18802434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of antihypertensive treatment based on plasma renin activity: An open label observational study.
    Leotta G; Rabbia F; Testa E; Totaro S; Abram S; Milan A; Mulatero P; Veglio F
    Blood Press; 2010 Aug; 19(4):218-24. PubMed ID: 20367559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT.
    Laragh JH; Sealey JE
    Am J Hypertens; 2003 May; 16(5 Pt 1):407-15. PubMed ID: 12745204
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Timolol, hydrochlorothiazide, blood-pressure, and renin in essential hypertension.
    Fyhrquist F; Kurppa K; Kannas M
    Lancet; 1976 Sep; 2(7987):691-2. PubMed ID: 60553
    [No Abstract]   [Full Text] [Related]  

  • 14. The prognostic implications of plasma renin in essential hypertension.
    Kaplan NM
    JAMA; 1975 Jan; 231(2):167-70. PubMed ID: 1172683
    [No Abstract]   [Full Text] [Related]  

  • 15. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.
    Semplicini A; Strapazzon G; Papparella I; Sartori M; Realdi A; Macchini L; Calò LA; Ceolotto G
    J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors.
    Zusman RM
    Kidney Int; 1984 Jun; 25(6):969-83. PubMed ID: 6088887
    [No Abstract]   [Full Text] [Related]  

  • 17. Is the plasma aldosterone-to-renin ratio associated with blood pressure response to treatment in general practice?
    Käyser SC; Schalk BWM; de Grauw WJC; Schermer TR; Akkermans RP; Lenders JWM; Deinum J; Biermans MCJ
    Fam Pract; 2019 Mar; 36(2):154-161. PubMed ID: 29788258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with prazosin in the treatment of patients with severe hypertension.
    Hayes JM; Graham RM; O'Connell BP; Muir MR; Speers E; Humphery TJ
    Med J Aust; 1976 Apr; 1(16):562-4. PubMed ID: 933955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin and prorenin as biomarkers in hypertension.
    Jan Danser AH
    Curr Opin Nephrol Hypertens; 2012 Sep; 21(5):508-14. PubMed ID: 22820372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma renin testing to guide antihypertensive therapy.
    Viera AJ; Furberg CD
    Curr Hypertens Rep; 2015 Jan; 17(1):506. PubMed ID: 25432898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.